MIR6817

Across TCGA pan-cancer cohorts, MIR6817 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR6817 data layer compared with 2 for mutation status.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher MIR6817 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6817 expression acts as an unfavorable survival marker, although some lineages such as LUAD and STAD show a favorable association.

ESCA, OV, and ACC are the cancer types where MIR6817 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	All	0.142	0.538	<.001	72	view →
OV	OS	Tertile	II,III,IV	0.463	0.696	.003	54	view →
ACC	DFS	Tertile	All	0.057	0.667	<.001	45	view →
CHOL	DFS	Tertile	All	0.045	0.497	.029	36	view →
UCEC	OS	Tertile	All	0.276	0.697	.001	36	view →
BLCA	DFS	Tertile	All	0.106	0.353	.010	27	view →
LIHC	OS	Tertile	II,III,IV	0.092	0.696	<.001	27	view →
COAD	OS	Tertile	III,IV	0.179	0.799	<.001	24	view →
LGG	DFS	Tertile	All	0.322	0.733	.012	18	view →
PCPG	OS	Tertile	All	0.763	0.974	.017	18	view →
LUAD	OS	Tertile	IV	0.511	0.378	.009	12	view →
STAD	OS	Tertile	II,III,IV	1.000	0.406	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR6817–ESCA (DFS)

Open the ESCA breakdown →